| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |